Reports for APOTEX INC

Company Name

APOTEX INC

Totals

Shortage reports

3020

Actual shortage: 236 (8%)
Anticipated shortage: 18 (1%)
Avoided shortage: 9 (0%)
Resolved: 2757 (91%)

Discontinuation Reports

356

To be discontinued: 22 (6%)
Discontinued: 334 (94%)
Reversed: 0 (0%)

Late reports

142 (4%)

Overdue reports

29 (11%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-DESVENLAFAXINE 50MG TABLET (EXTENDED-RELEASE) Resolved 2018-07-16 2018-10-02 55836
APO-METHYLPHENIDATE ER 54MG TABLET (EXTENDED-RELEASE) Resolved 2018-07-25 2018-10-25 56541
APO-METHYLPHENIDATE ER 18MG TABLET (EXTENDED-RELEASE) Resolved 2018-10-25 2018-11-22 65599
APO-QUETIAPINE XR 200MG TABLET (EXTENDED-RELEASE) Resolved 2018-11-09 2020-11-03 66543
APO-METHYLPHENIDATE ER 54MG TABLET (EXTENDED-RELEASE) Resolved 2018-11-30 2019-06-13 68225
APO-METFORMIN ER 500MG TABLET (EXTENDED-RELEASE) Resolved 2018-12-18 2019-01-28 69915
APO-METHYLPHENIDATE ER 27MG TABLET (EXTENDED-RELEASE) Resolved 2018-12-18 2019-07-17 69918
APO-OXYCODONE CR 60MG TABLET (EXTENDED-RELEASE) Resolved 2018-12-18 2019-02-08 69921
APO-METHYLPHENIDATE ER 36MG TABLET (EXTENDED-RELEASE) Resolved 2018-12-19 2019-07-17 70146
APO-DESVENLAFAXINE 50MG TABLET (EXTENDED-RELEASE) Resolved 2019-01-03 2019-01-17 71118
APO-METHYLPHENIDATE ER 18MG TABLET (EXTENDED-RELEASE) Resolved 2019-01-03 2019-05-17 71136
APO-TAMSULOSIN CR 0.4MG TABLET (EXTENDED-RELEASE) Resolved 2019-01-15 2019-02-21 72363
APO-QUETIAPINE XR 50MG TABLET (EXTENDED-RELEASE) Resolved 2019-01-30 2020-11-03 74033
APO-DESVENLAFAXINE 50MG TABLET (EXTENDED-RELEASE) Resolved 2019-02-21 2019-04-05 76582
APO-METFORMIN ER 1000MG TABLET (EXTENDED-RELEASE) Resolved 2019-02-24 2019-04-15 76726
APO-QUETIAPINE XR 150MG TABLET (EXTENDED-RELEASE) Resolved 2019-02-24 2020-11-03 76735
APO-QUETIAPINE XR 400MG TABLET (EXTENDED-RELEASE) Resolved 2019-02-24 2020-11-03 76740
APO-DESVENLAFAXINE 100MG TABLET (EXTENDED-RELEASE) Resolved 2019-04-10 2019-05-14 80926
APO-TAMSULOSIN CR 0.4MG TABLET (EXTENDED-RELEASE) Resolved 2019-04-24 2019-06-21 82337
APO-DESVENLAFAXINE 50MG TABLET (EXTENDED-RELEASE) Resolved 2019-04-30 2019-05-13 82837

Showing 101 to 120 of 3020

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-LOPERAMIDE 2MG TABLET Discontinued 2017-03-31 2017-03-31 4930
APO-SOTALOL 80MG TABLET Discontinued 2017-03-31 2018-12-07 4936
APO-ACEBUTOLOL 400MG TABLET Discontinued 2017-03-31 2018-02-05 4965
APO-OLANZAPINE 5.0MG TABLET Discontinued 2017-03-31 2018-02-05 4968
APO-SOTALOL 160MG TABLET Discontinued 2017-03-31 2018-02-05 4971
APO-TERAZOSIN 2MG TABLET Discontinued 2017-03-31 2018-02-05 4974
APO-IRBESARTAN/HCTZ 12.5MG 150MG TABLET Discontinued 2018-02-23 2018-02-23 40757
APO-IRBESARTAN/HCTZ 12.5MG 150MG TABLET Discontinued 2018-02-23 2018-07-17 40760
APO-IRBESARTAN/HCTZ 25MG 300MG TABLET Discontinued 2018-02-23 2018-09-15 40766
APO-IRBESARTAN/HCTZ 25MG 300MG TABLET Discontinued 2018-02-23 2018-09-15 40769
APO-METFORMIN 850MG TABLET Discontinued 2018-02-23 2019-06-12 40778
APO-METFORMIN 500MG TABLET To be discontinued 2018-02-23 2018-12-28 40781
APO-METFORMIN 500MG TABLET To be discontinued 2018-02-23 2018-12-28 40784
APO-METFORMIN 500MG TABLET Discontinued 2018-02-23 2018-11-26 40790
APO-METFORMIN 850MG TABLET Discontinued 2018-02-23 2018-09-15 40796
APO-TELMISARTAN 40MG TABLET Discontinued 2018-02-23 2018-09-15 40811
APO-TELMISARTAN 40MG TABLET Discontinued 2018-02-23 2018-09-15 40814
APO-TELMISARTAN 80MG TABLET Discontinued 2018-02-23 2018-09-15 40817
APO-TELMISARTAN 80MG TABLET Discontinued 2018-02-23 2018-09-15 40820
APO-TELMISARTAN/HCTZ 12.5MG 80MG TABLET Discontinued 2018-02-23 2018-09-15 40823

Showing 41 to 60 of 356